awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48226075-7D0E3F78-ABBE-4093-B56C-8AA45F4CB7D7
Q48226075-7D0E3F78-ABBE-4093-B56C-8AA45F4CB7D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48226075-7D0E3F78-ABBE-4093-B56C-8AA45F4CB7D7
Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.
P2860
Q48226075-7D0E3F78-ABBE-4093-B56C-8AA45F4CB7D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48226075-7D0E3F78-ABBE-4093-B56C-8AA45F4CB7D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61fb4aa362be0c4bcc82e338b0bd20a63933103e
P2860
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.